Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

[1]  K. Morikane,et al.  [Pandemic influenza]. , 2012, Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology.

[2]  Benjamin J. Cowling,et al.  Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study , 2011, PLoS medicine.

[3]  T. Strutt,et al.  Hallmarks of CD4 T cell immunity against influenza , 2011, Journal of internal medicine.

[4]  Francisco A. Chaves,et al.  Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus , 2010, The Journal of Immunology.

[5]  Samson S. Y. Wong,et al.  The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment , 2010, Chest.

[6]  E. James,et al.  Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell Responses to 2009 Pandemic H1N1 Swine-Origin Influenza A Virus , 2010, Journal of Virology.

[7]  Jason S. Schwarz,et al.  Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza , 2010, PloS one.

[8]  Francisco A. Chaves,et al.  Cutting Edge : CD 4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H 1 N 1 Virus , 2010 .

[9]  A. Iwasaki,et al.  CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.

[10]  T. Braciale,et al.  Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10 , 2009, Nature Medicine.

[11]  N. Khardori,et al.  Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 , 2009 .

[12]  A. Iwasaki,et al.  CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.

[13]  P. Doherty,et al.  Killer T cells in influenza. , 2008, Pharmacology & therapeutics.

[14]  J. Farrar,et al.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. , 2008, The Journal of clinical investigation.

[15]  G. Rimmelzwaan,et al.  Correlates of protection: novel generations of influenza vaccines. , 2008, Vaccine.

[16]  I. Berge,et al.  Cytotoxic human CD4(+) T cells. , 2008 .

[17]  Junbao Yang,et al.  Healthy Human Subjects Have CD4+ T Cells Directed against H5N1 Influenza Virus1 , 2008, The Journal of Immunology.

[18]  E. Wherry,et al.  Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection , 2007, The Journal of experimental medicine.

[19]  P. Doherty,et al.  A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.

[20]  T. Kuiken,et al.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. , 2007, Vaccine.

[21]  R. Koup,et al.  Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation , 2006, The Journal of experimental medicine.

[22]  B. Schweiger,et al.  Reassortment between human A(H3N2) viruses is an important evolutionary mechanism. , 2006, Vaccine.

[23]  David E. Swayne,et al.  Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus , 2006, Nature.

[24]  R. Belshe,et al.  The origins of pandemic influenza--lessons from the 1918 virus. , 2005, The New England journal of medicine.

[25]  Su Wang,et al.  Memory T-Cell Response to Rotavirus Detected with a Gamma Interferon Enzyme-Linked Immunospot Assay , 2005, Journal of Virology.

[26]  J. Oxford,et al.  Would you volunteer to be quarantined and infected with influenza virus? , 2005, Expert review of anti-infective therapy.

[27]  M. Bevan.  Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.

[28]  J. Treanor.  Influenza vaccine--outmaneuvering antigenic shift and drift. , 2004, The New England journal of medicine.

[29]  M. Caulfield,et al.  Identification of T-cell epitopes using ELISpot and peptide pool arrays. , 2004, Methods in molecular medicine.

[30]  R. Belshe,et al.  Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent. , 2003, Immunology and allergy clinics of North America.

[31]  Edward C Holmes,et al.  Error thresholds and the constraints to RNA virus evolution , 2003, Trends in Microbiology.

[32]  Harry Greenberg,et al.  Novel generations of influenza vaccines. , 2003, Vaccine.

[33]  R. Couch.  An overview of serum antibody responses to influenza virus antigens. , 2003, Developments in biologicals.

[34]  Anthony D. Kelleher,et al.  Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.

[35]  A. Monto.  Epidemiology and Virology of Influenza Illness , 2000 .

[36]  J. Treanor,et al.  Clinical and laboratory diagnosis of influenza virus infections. , 2000, The American journal of managed care.

[37]  B. Lina,et al.  Surveillance and impact of influenza in Europe , 1999 .

[38]  B. Lina,et al.  Surveillance and impact of influenza in Europe. Groupe Régional d'Observation de la Grippe and European Influenza Surveillance Scheme. , 1999, Vaccine.

[39]  Spyros A. Kalams,et al.  The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.

[40]  C. Thompson,et al.  Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28 , 1998, The Journal of experimental medicine.

[41]  P. Doherty,et al.  CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. , 1997, Journal of immunology.

[42]  R P Johnson,et al.  Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes , 1996, Journal of virology.

[43]  Glezen Wp.  Emerging Infections: Pandemic Influenza , 1996 .

[44]  Glezen Wp,et al.  Emerging infections: pandemic influenza. , 1996, Epidemiologic reviews.

[45]  N. Cox,et al.  Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites , 1983, Journal of virology.

[46]  A. McMichael,et al.  Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.

[47]  P. Ho,et al.  Plaque formation with influenza viruses in dog kidney cells. , 1976, The Journal of general virology.